| NCT ID | NCT05269472 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Minnesota |
| Condition | Trigeminal Neuralgia |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2022-04-04 |
| Primary Completion | 2027-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2022-04-04 with a primary completion date of 2027-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study intervention is to perform standard somatosensory evoked responses limited to the face during rhizotomy procedures of the gasserian ganglion (trigeminal ganglion) for the treatment of trigeminal neuralgia. The evoked responses will be measured at two locations before and after the clinical rhizotomy including: the standard contralateral scalp (EEG) and at the gasserian ganglion through an FDA-approved recording electrode.
Eligibility Criteria
Inclusion Criteria (TGN): * Adults of 18 years or older * Scheduled to undergo percutaneous rhizotomy for facial pain Exclusion Criteria (TGN): * Facial pain of unclear origin (i.e. not clearly TGN pain) * Rhizotomy procedure canceled Inclusion Criteria (Healthy controls) * Adults of 18 years or older Exclusion Criteria (Healthy Controls) * Diagnosis or history of facial pain such as TMD or TGN * History of migraine * History of any functional pain disorder: fibromyalgia, IBS, CRPS * Recent chronic pain (within last month) * Unwilling to participate for two hours in lab * Current acute pain
Contact & Investigator
David Darrow
PRINCIPAL INVESTIGATOR
University of Minnesota
Frequently Asked Questions
Who can join the NCT05269472 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Trigeminal Neuralgia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05269472 currently recruiting?
Yes, NCT05269472 is actively recruiting participants. Contact the research team at maple036@umn.edu for enrollment information.
Where is the NCT05269472 trial being conducted?
This trial is being conducted at Minneapolis, United States.
Who is sponsoring the NCT05269472 clinical trial?
NCT05269472 is sponsored by University of Minnesota. The principal investigator is David Darrow at University of Minnesota. The trial plans to enroll 30 participants.